Serum

SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years

COVID Vaccine: Govt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults

Serum Institute Seeks EUA For Its Covovax Vaccine For 12-17 Years Age Group

Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population

Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval

SII Gets DCGI Nod To Manufacture Drug Substance, Test It For Developing Jab Against Omicron

CDSCO Panel Recommends Emergency Use Authorisation For SII's Covid vaccine Covovax

Covovax Covid Vaccine Gets WHO Approval, Adar Poonawalla Calls It 'Another Milestone'

Covid Vaccine For Children Aged 3 Plus To Be Launched By June 2022: SII CEO Adar Poonawala

Amid Omicron Fear, Expert Committee Gives No Recommendations For COVID Booster Dose: Report

Omicron Scare: Subject Expert Committee To Hold Meeting Tomorrow Over Booster Doses

SII Executive Director Dr Suresh Jadhav, 72, Passes Away In Pune